TY - JOUR
T1 - Decreased response to social defeat stress in μ-opioid-receptor knockout mice
AU - Komatsu, Hiroshi
AU - Ohara, Arihisa
AU - Sasaki, Kazumasu
AU - Abe, Hiromi
AU - Hattori, Hisaki
AU - Hall, F. Scott
AU - Uhl, George R.
AU - Sora, Ichiro
N1 - Funding Information:
The authors thank Harumi Hata, Tomomi Nakano, Dr. Hideaki Kobayashi, Dr. Yohtaro Numachi, Dr. Motoyasu Yamashita, and Dr. Fumiaki Ito for technical assistance and scientific advice. This study was supported by a Grant-in-Aid for Health and Labor Science Research (Research on Pharmaceutical and Medical Safety) from the Ministry of Health, Labor and Welfare of Japan ; by Grants-in-Aid for Scientific Research on Priority Areas–System Study on Higher Order Brain Functions and Research on Pathomechanisms of Brain Disorders from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Nos. 17022007 , 18023007 ); and by the Intramural Research Program of the National Institute on Drug Abuse (NIH/DHHS, USA) .
PY - 2011/10
Y1 - 2011/10
N2 - Substantial evidence exists that opioid systems are involved in stress response and that changes in opioid systems in response to stressors affect both reward and analgesia. Reportedly, mice suffering chronic social defeat stress subsequently show aversion to social contact with unfamiliar mice. To further examine the role of opioid systems in stress response, the behavioral and neurochemical effects of chronic social defeat stress (psychosocial stress) were evaluated in μ-opioid-receptor knockout (MOR-KO) mice. Aversion to social contact was induced by chronic social defeat stress in wild-type mice but was reduced in MOR-KO mice. Moreover, basal expression of brain-derived neurotrophic factor (BDNF) mRNA in MOR-KO mice hippocampi was significantly lower than in wild-type mice. Psychosocial stress significantly decreased BDNF mRNA expression in wild-type mice but did not affect BDNF expression in MOR-KO mice; no difference in basal levels of plasma corticosterone was observed. These results suggest that the μ-opioid receptor is involved in the behavioral sequelae of psychosocial stress and consequent regulation of BDNF expression in the hippocampus, and may play an important role in psychiatric disorders for which stress is an important predisposing or precipitating factor, such as depression, posttraumatic stress disorder, and social anxiety disorder.
AB - Substantial evidence exists that opioid systems are involved in stress response and that changes in opioid systems in response to stressors affect both reward and analgesia. Reportedly, mice suffering chronic social defeat stress subsequently show aversion to social contact with unfamiliar mice. To further examine the role of opioid systems in stress response, the behavioral and neurochemical effects of chronic social defeat stress (psychosocial stress) were evaluated in μ-opioid-receptor knockout (MOR-KO) mice. Aversion to social contact was induced by chronic social defeat stress in wild-type mice but was reduced in MOR-KO mice. Moreover, basal expression of brain-derived neurotrophic factor (BDNF) mRNA in MOR-KO mice hippocampi was significantly lower than in wild-type mice. Psychosocial stress significantly decreased BDNF mRNA expression in wild-type mice but did not affect BDNF expression in MOR-KO mice; no difference in basal levels of plasma corticosterone was observed. These results suggest that the μ-opioid receptor is involved in the behavioral sequelae of psychosocial stress and consequent regulation of BDNF expression in the hippocampus, and may play an important role in psychiatric disorders for which stress is an important predisposing or precipitating factor, such as depression, posttraumatic stress disorder, and social anxiety disorder.
KW - Behavior
KW - Brain-derived neurotrophic factor
KW - Chronic social defeat stress
KW - Hippocampus
KW - μ-opioid-receptor knockout
UR - http://www.scopus.com/inward/record.url?scp=79960291815&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79960291815&partnerID=8YFLogxK
U2 - 10.1016/j.pbb.2011.06.008
DO - 10.1016/j.pbb.2011.06.008
M3 - Article
C2 - 21703297
AN - SCOPUS:79960291815
SN - 0091-3057
VL - 99
SP - 676
EP - 682
JO - Pharmacology Biochemistry and Behavior
JF - Pharmacology Biochemistry and Behavior
IS - 4
ER -